Pharma industry expects lower revenue amid tariff dispute with Trump
The pharmaceutical industry anticipates revenue declines due to potential trade disputes and tariff policies involving Donald Trump.
The pharmaceutical industry anticipates revenue declines due to potential trade disputes and tariff policies involving Donald Trump.